Dagmar Rosa-Bjorkeson was appointed Chief Operating Officer (COO) of Mesoblast Limited in July 2020. Based in New York, USA.
Dagmar Rosa-Bjorkeson was appointed Chief Operating Officer (COO) of Mesoblast Limited in July 2020. Based in New York, her responsibilities include managing commercial operations, leading business units, building strategic alliances, and overseeing product launches. She brings over 25 years of global pharmaceutical industry experience, having led multiple successful product launches.
Full founder directory · Investor directory · Company funding database · Fundraising library